[go: up one dir, main page]

MX2010005702A - Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel. - Google Patents

Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel.

Info

Publication number
MX2010005702A
MX2010005702A MX2010005702A MX2010005702A MX2010005702A MX 2010005702 A MX2010005702 A MX 2010005702A MX 2010005702 A MX2010005702 A MX 2010005702A MX 2010005702 A MX2010005702 A MX 2010005702A MX 2010005702 A MX2010005702 A MX 2010005702A
Authority
MX
Mexico
Prior art keywords
preparation
skin cosmetics
acid polysaccharides
formic esters
butyric
Prior art date
Application number
MX2010005702A
Other languages
English (en)
Inventor
Luca Stucchi
Marco Bosco
Rita Gianni
Antonia Trevisan
Original Assignee
Sigea Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigea Srl filed Critical Sigea Srl
Publication of MX2010005702A publication Critical patent/MX2010005702A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se exponen polisacáridos caracterizados por la presencia concomitante de grupos alcohol esterificados con ácidos butírico y fórmico.
MX2010005702A 2007-11-27 2008-11-20 Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel. MX2010005702A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002237A ITMI20072237A1 (it) 2007-11-27 2007-11-27 Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici
PCT/EP2008/009801 WO2009068215A1 (en) 2007-11-27 2008-11-20 Mixed butyric-formic esters of acid polysaccharides, and their preparation and use as skin cosmetics

Publications (1)

Publication Number Publication Date
MX2010005702A true MX2010005702A (es) 2010-08-31

Family

ID=40314765

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005702A MX2010005702A (es) 2007-11-27 2008-11-20 Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel.

Country Status (18)

Country Link
US (1) US8530450B2 (es)
EP (1) EP2222713B1 (es)
JP (1) JP6000511B2 (es)
KR (1) KR101571385B1 (es)
CN (1) CN101925613B (es)
BR (1) BRPI0820393B1 (es)
CA (1) CA2706782C (es)
ES (1) ES2660847T3 (es)
IL (1) IL205968A (es)
IT (1) ITMI20072237A1 (es)
MX (1) MX2010005702A (es)
NZ (1) NZ585699A (es)
PL (1) PL2222713T3 (es)
PT (1) PT2222713T (es)
RU (1) RU2490280C2 (es)
UA (1) UA98180C2 (es)
WO (1) WO2009068215A1 (es)
ZA (1) ZA201003764B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509289A (ja) 2008-11-20 2012-04-19 ラボラトリ・デリバティ・オルガニシ・エス・ピー・エイ ヘパラン硫酸の精製方法並びに美容用及び皮膚用調製物中におけるその使用
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
CN103724455B (zh) * 2013-12-11 2016-07-06 四川大学 一种透明质酸衍生物及其水凝胶的制备方法
PL3245233T3 (pl) 2015-01-13 2019-06-28 Bmg Pharma S.P.A. Sposób wytwarzania w wodzie estrów soli sodowej kwasu hialuronowego z kwasem masłowym
CN113456662B (zh) * 2019-09-30 2022-12-09 中检科医药科技(北京)集团有限公司 低分子量硫酸软骨素在制备日化产品和外用制剂中的用途
IT201900021693A1 (it) * 2019-11-20 2021-05-20 Bmg Pharma S P A Derivati butirrati o butirrati e formiati dell’acido ialuronico reticolati e loro procedimento di reticolazione
IT202000001831A1 (it) * 2020-01-30 2021-07-30 Caprika Srl Composizione per applicazione rettale a base di sale di acido butirrico per il trattamento delle patologie proctologiche
IT202000016984A1 (it) 2020-07-13 2022-01-13 Bmg Pharma S P A Composizioni igienizzanti e antiinfettive per le mucose orali
CN116589606B (zh) * 2022-12-01 2024-05-28 中国药科大学 一种丁酰化酵母葡聚糖及其制备方法、应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB487020A (en) * 1936-10-29 1938-06-14 British Celanese Improvements in or relating to the manufacture of esters of polysaccharides
US2589226A (en) * 1946-11-22 1952-03-18 Us Agriculture Acylation of polysaccharides in formamide
JPS469327B1 (es) * 1966-03-31 1971-03-09
JPS52111983A (en) * 1976-03-18 1977-09-20 Teijin Ltd Preparation of heparin derivatives
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
ITTS20010013A1 (it) * 2001-06-04 2002-12-04 Ct Ricerche Poly Tec H A R L S Nuovi derivati di ialuronano.
ITTS20010017A1 (it) * 2001-07-17 2003-01-17 Ct Ricerche Polytech Soc Coop Esteri polisaccaridici di acido retinoico.
ITMI20022745A1 (it) * 2002-12-23 2004-06-24 Coimex Scrl United Companies Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.
CN102276732B (zh) 2003-11-28 2016-01-20 伊士曼化工公司 纤维素共聚体和氧化方法
ITMI20040347A1 (it) * 2004-02-26 2004-05-26 Pharma Medical Ltd Nuovo farmaco di associazione
ITMI20040605A1 (it) * 2004-03-29 2004-06-29 Coimex S C R L United Companie Esteri butirrici dell'acido ialuronico a basso grado di sostituzione procedimento per la loro preparazione ed uso
KR20130109259A (ko) * 2005-10-12 2013-10-07 세이가가쿠 고교 가부시키가이샤 점막에 적용하는 작용제 및 그것의 제조 방법
EP1942117A1 (en) * 2006-12-29 2008-07-09 Sigea S.R.L. Derivatives of acid polysaccharides

Also Published As

Publication number Publication date
WO2009068215A1 (en) 2009-06-04
ES2660847T3 (es) 2018-03-26
IL205968A0 (en) 2010-11-30
CN101925613B (zh) 2012-11-21
RU2010121133A (ru) 2011-11-27
KR20100092494A (ko) 2010-08-20
US8530450B2 (en) 2013-09-10
ZA201003764B (en) 2011-08-31
UA98180C2 (ru) 2012-04-25
JP2011504950A (ja) 2011-02-17
AU2008329154A1 (en) 2009-06-04
ITMI20072237A1 (it) 2009-05-28
EP2222713A1 (en) 2010-09-01
PL2222713T3 (pl) 2018-06-29
BRPI0820393B1 (pt) 2019-04-02
KR101571385B1 (ko) 2015-11-24
RU2490280C2 (ru) 2013-08-20
US20100305061A1 (en) 2010-12-02
BRPI0820393A2 (pt) 2015-05-19
CN101925613A (zh) 2010-12-22
CA2706782C (en) 2016-09-13
EP2222713B1 (en) 2018-01-10
IL205968A (en) 2014-03-31
PT2222713T (pt) 2018-03-01
CA2706782A1 (en) 2009-06-04
JP6000511B2 (ja) 2016-09-28
NZ585699A (en) 2011-09-30

Similar Documents

Publication Publication Date Title
MX2010005702A (es) Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel.
WO2011023355A3 (en) Viscoelastic gels as novel fillers
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
MY205872A (en) Pharmaceutical compositions comprising omega-3 fatty acids
WO2011127409A3 (en) Methods and compositions related to fatty alcohol biosynthetic enzymes
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
WO2014093505A8 (en) Acp-mediated production of fatty acid derivatives
WO2009002456A3 (en) Methods and compositions relating to progenitor cells
PH12012501755A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
WO2008028117A3 (en) Glp-2 mimetibodies, polypeptides, compositions, methods and uses
CO6351813A2 (es) "metodos y composiciones para mejorar la produccion de productos en microorganismos"
EP2246042A3 (en) Compositions and methods for treating signs of skin aging
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2007136679A3 (en) Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
WO2012163868A3 (en) Composition comprising an alkoxysilane, a fatty ester and a silicone, and cosmetic use thereof
WO2013016668A3 (en) Methylphenidate-prodrugs, processes of making and using the same
HK1201486A1 (en) Composition containing an extract of a sequential or simultaneous fermentation
CA2835730C (en) Molecular markers in prostate cancer
WO2009120919A3 (en) Fenofibrate dosage forms
EP2522337A3 (en) Hyaluronic acid esters, their preparation and use in dermatology
EP2319488A3 (en) Compositions comprising an NFkB-inhibitor and a tropoelastin promoter
WO2009008656A3 (en) A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof
WO2008107092A3 (en) Use of derivatives of 4-hydroxyphenoxy acetic acid
WO2014037903A3 (en) Cosmetic compositions comprising eicosapentaeninic free acid and gamma-linopenic free acid and methods of making and using same
WO2014096187A3 (en) A cosmetic composition from fish hatching fluid, methods for its production and uses thereof for improving the cosmetic appearance of skin

Legal Events

Date Code Title Description
FG Grant or registration